AAIS
IDXX icon

ABN AMRO Investment Solutions’s Idexx Laboratories IDXX Stock Holding History

ABN AMRO Investment Solutions’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.56M Buy
4,867
+1,077
+28% +$604K 0.02% 360
2026
Q1 		$2.13M Buy
3,790
+268
+8% +$172K 0.03% 346
2025
Q4 		$2.38M Buy
3,522
+539
+18% +$367K 0.04% 298
2025
Q3 		$1.91M Sell
2,983
-300
-9% -$182K 0.04% 253
2025
Q2 		$1.76M Buy
3,283
+675
+26% +$323K 0.04% 258
2025
Q1 		$1.1M Buy
2,608
+35
+1% +$15.2K 0.02% 287
2024
Q4 		$1.06M Sell
2,573
-1,218
-32% -$534K 0.02% 299
2024
Q3 		$1.92M Sell
3,791
-1,906
-33% -$926K 0.03% 265
2024
Q2 		$2.78M Sell
5,697
-454
-7% -$228K 0.05% 219
2024
Q1 		$3.32M Buy
6,151
+78
+1% +$42.6K 0.06% 209
2023
Q4 		$3.37M Sell
6,073
-752
-11% -$353K 0.06% 216
2023
Q3 		$2.98M Buy
6,825
+1,409
+26% +$703K 0.06% 222
2023
Q2 		$2.72M Buy
5,416
+1,100
+25% +$527K 0.05% 218
2023
Q1 		$2.16M Buy
+4,316
New +$2.07M 0.04% 242

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

ABN AMRO Investment Solutions's IDXX Position: Q2 2026 in Review

ABN AMRO Investment Solutions increased its Idexx Laboratories (IDXX) stake by 28% in Q2 2026, buying an estimated $604K and bringing the position to 4,867 shares worth $2.56M. The position accounts for 0.02% of the portfolio, ranked #360.

ABN AMRO Investment Solutions first reported a position in IDXX in Q1 2023 and has held it in 14 quarters since. The position peaked at $3.37M in Q4 2023. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • ABN AMRO Investment Solutions held 4,867 shares of Idexx Laboratories worth $2.56M as of Q2 2026.
  • ABN AMRO Investment Solutions bought 1,077 Idexx Laboratories shares in Q2 2026, an estimated $604K.
  • Idexx Laboratories made up 0.02% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #360 holding.
  • ABN AMRO Investment Solutions first reported a position in Idexx Laboratories in Q1 2023 and has held it in 14 quarters since.
  • ABN AMRO Investment Solutions's Idexx Laboratories position peaked at $3.37M in Q4 2023.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.